A pH-Responsive Cluster Metal-Organic Framework Nanoparticle for Enhanced Tumor Accumulation and Antitumor Effect

Ruoyu Cheng1,2,3,4, Lingxi Jiang1,5, Han Gao2,4

  • 1Department of General Surgery, Pancreatic Disease Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin Second Road, Shanghai, 200025, P. R. China.

Insights

This study developed pH-responsive nanoparticles that enhance drug accumulation in tumors. The novel nanoparticles improve cancer treatment efficacy and increase survival rates in mice with minimal organ toxicity.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Materials Science

Background:

  • Metal-organic framework nanoparticles show limited tumor accumulation due to off-target effects and protein corona.
  • Targeted delivery systems are crucial for enhancing therapeutic efficacy in cancer treatment.

Purpose of the Study:

  • To develop a pH-responsive nanoparticle system for improved tumor targeting and therapeutic effect.
  • To investigate the efficacy of apilimod-loaded zeolitic imidazolate framework coated with solid lipid nanoshells and pH-responsive linkers.

Main Methods:

  • Synthesized pH-responsive linkers by modifying oleylamine with MMfu and PEG.
  • Encapsulated apilimod-loaded zeolitic imidazolate framework within solid lipid nanoshells, functionalized with pH-responsive linkers (Ap-ZIF@SLN#L).
  • Evaluated nanoparticle uptake, tumor accumulation, therapeutic efficacy, and in vivo safety in tumor-bearing mice models.

Main Results:

  • The pH-responsive linker facilitated nanoparticle disassembly in the tumor microenvironment, exposing hydrophobic moieties for enhanced cellular uptake and tumor accumulation.
  • Ap-ZIF@SLN#L treatment significantly inhibited tumor growth, increased survival rates, and promoted anti-tumor immune responses by enhancing macrophage and T cell infiltration.
  • Nanoparticle treatment demonstrated no significant toxicity to major organs, maintaining normal tissue structure and serum enzyme levels.

Conclusions:

  • The developed pH-responsive nanoparticle system effectively targets tumors and enhances the therapeutic effects of apilimod.
  • This strategy offers a promising approach for improving cancer therapy by overcoming nanoparticle delivery challenges.
  • The nanoparticles exhibit favorable safety profiles, suggesting their potential for clinical translation.

Related Concept Videos